Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing
Min Soo Cho, Ji Eun Yun, Ji Jeong Park, Yun Jung Kim, Jessie Lee, Hyungmin Kim, Duk‐Woo Park, Gi‐Byoung Nam
Topics & Concepts
MedicineApixabanRivaroxabanDosingVitamin K antagonistWarfarinAtrial fibrillationInternal medicineStroke (engine)EngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsVenous Thromboembolism Diagnosis and Management